CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $572.5M, above the global median of $548.88M
- FinancialsAltman Z-Score 3.28: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.70%Below 5Y avg (1.74%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
36.5%Sustainable
Payback Period
58.5 yr
Last Ex-Dividend
Jun 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.45BCNY814.21M · vs all stocks (USD)
Trailing P/E
21.07xvs Medical Instruments & Supplies peers
Revenue (TTM)
3.83BCNY572.50M · vs all stocks (USD)
Profit Margin
6.33%vs Medical Instruments & Supplies peers
Beta
0.2280xvs all stocks
52-Week Change
-9.08%vs all stocks
Market Capitalization
5.45BCNY814.21M · vs all stocks (USD)
Enterprise Value
5.97BCNY891.39M · vs all stocks (USD)
Trailing P/E
21.07xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.39xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.40xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.56xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
7.16xvs Medical Instruments & Supplies peers
Gross Margin
29.79%vs Medical Instruments & Supplies peers
Profit Margin
6.33%vs Medical Instruments & Supplies peers
Operating Margin
14.21%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
6.85%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
7.07%vs Medical Instruments & Supplies peers
Revenue (TTM)
3.83BCNY572.50M · vs all stocks (USD)
Revenue per Share (TTM)
6.28CNYUpdated Sep 21, 2026Quarterly Revenue Growth
2.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.16BCNY173.31M · vs all stocks (USD)
EBITDA (TTM)
570.97MCNY85.26M · vs all stocks (USD)
Net Income (TTM)
242.57MCNY36.22M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-25.40%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
331.24MCNY49.46M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-22.96MCNY-3.43M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1460CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.70%vs all stocks
5-Year Average Dividend Yield
1.74%vs all stocks
Payout Ratio
36.45%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
19.77MCNYFY2025 · Dec 31, 2025Revenue
3.67BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.62BCNYFY2025 · Dec 31, 2025Gross Profit
1.05BCNYFY2025 · Dec 31, 2025Operating Income
594.90MCNY88.84M · vs all stocks (USD)
Pre-tax Income
309.02MCNYFY2025 · Dec 31, 2025Income Tax Expense
51.87MCNYFY2025 · Dec 31, 2025Net Income
257.15MCNYFY2025 · Dec 31, 2025EBIT
326.69MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
812.92MCNYFY2025 · Dec 31, 2025Research & Development
104.05MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
122.11MCNYFY2025 · Dec 31, 2025Other Operating Expenses
33.15MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
16.67MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
17.67MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4022CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4022CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
618.81MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
618.81MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
257.15MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-8.26MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
82.46MCNYFY2025 · Dec 31, 2025Free Cash Flow
-177.85MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
965.72MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
257.15MCNYFY2025 · Dec 31, 2025Other Non-cash Items
33.09MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-120.22MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-87.55MCNYFY2025 · Dec 31, 2025Capital Expenditures
-260.31MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.19BCNYFY2025 · Dec 31, 2025Sale of Investments
1.18BCNYFY2025 · Dec 31, 2025Other Investing Activity
3.61MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-266.09MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
594.01MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-637.35MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-52.34MCNYFY2025 · Dec 31, 2025Other Financing Charges
30.51MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-65.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
633.27MSharesUpdated Sep 21, 2026Float Shares
363.96MSharesUpdated Sep 21, 2026% Held by Insiders
62.43%vs all stocks
% Held by Institutions
3.85%vs all stocks
Total Cash (MRQ)
471.75MCNY70.45M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7670CNYUpdated Sep 21, 2026Total Debt (MRQ)
1.22BCNY182.40M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3280xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.59xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.00CNYUpdated Sep 21, 2026Total Assets
5.61BCNY837.32M · vs all stocks (USD)
Total Current Assets
2.40BCNYFY2025 · Dec 31, 2025Total Liabilities
1.99BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.20BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
663.12MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.33BCNYFY2025 · Dec 31, 2025Cash
965.18MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.44MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
967.62MCNYFY2025 · Dec 31, 2025Other Short-term Investments
4.56MCNYFY2025 · Dec 31, 2025Accounts Receivable
517.70MCNYFY2025 · Dec 31, 2025Inventory
720.30MCNYFY2025 · Dec 31, 2025Accounts Payable
476.22MCNYFY2025 · Dec 31, 2025Short-term Debt
634.24MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.21MCNYFY2025 · Dec 31, 2025Long-term Debt
173.34MCNYFY2025 · Dec 31, 2025Common Stock (Book)
633.27MCNYFY2025 · Dec 31, 2025Retained Earnings
2.25BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.61BCNY539.80M · vs all stocks (USD)
Treasury Stock
148.52MCNYFY2025 · Dec 31, 202552-Week Low
8.33CNYUpdated Sep 21, 202652-Week High
14.90CNYUpdated Sep 21, 202652-Week Change
-9.08%vs all stocks
Beta
0.2280xvs all stocks
50-Day MA
9.08CNYUpdated Sep 21, 2026200-Day MA
10.75CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.93MSharesUpdated Sep 21, 2026Avg 30-Day Volume
6.02MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.4000CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.28: safe zoneNotable
Altman Z-Score: 3.28
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $572.5M, above the global median of $548.88MNotable
Revenue (USD): 572,497,406.909Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Shandong Link Science And Technology Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jintuo Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Longtu Photomask Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Mishra Dhatu Nigam Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shandong Nanshan Fashion Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
R&S Group Holding AG
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Ability Opto-Electronics Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Pourin Special Welding Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangdong Meiyan Jixiang Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Zhongchen Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Golden Long Teng Development Co., Ltd.
1 interpretationPrice Below Mean With Profitability And Book Value
Sichuan Mingxing Electric Co., Ltd.
1 interpretationPrice Below Mean With Profitability And Book Value
Ningbo Tuopu Group Co., Ltd.
1 interpretationPrice Below Mean With Profitability And Book Value